Nathaniel Gardiner

Currently holds a position at Enanta Pharmaceuticals Inc

0.5

0.5

Position	Company	Period
Senior Vice President, General Counsel	Enanta Pharmaceuticals Inc	May 1, 2014 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Enanta Pharmaceuticals Inc (ENTA)

Transaction date 5 Dec 2023

Sale

Price

379.87

Quantity 69,635 +46.2%

Value US$1,387,754

Comments Filing

Enanta Pharmaceuticals Inc (ENTA)

Transaction date 13 Feb 2019

Planned sale

Price

179.41

Quantity 26,066 -21.6%

Value US$2,214,765

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2023-12-06	2023-12-05	Enanta Pharmaceuticals Inc (ENTA)	S Sale	69,635 +46.2% 379.87 US$1,387,754	69,635 +46.2%	379.87	US$1,387,754
2019-02-13	2019-02-13	Enanta Pharmaceuticals Inc (ENTA)	PlS Planned sale	26,066 -21.6% 179.41 US$2,214,765	26,066 -21.6%	179.41	US$2,214,765